肌醇1,2,3,4,5,6-六[六（苯基甲基）磷酸酯] | 1287268-40-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 肌醇1,2,3,4,5,6-六[六（苯基甲基）磷酸酯]
• 英文名称: myo-Inositol 1,2,3,4,5,6-Hexakis[bis(phenylmethyl) Phosphate]
• 英文别名: dibenzyl [2,3,4,5,6-pentakis[bis(phenylmethoxy)phosphoryloxy]cyclohexyl] phosphate
• CAS: 1287268-40-9
• 化学式: C₉₀H₉₀O₂₄P₆
• 分子量: 1741.5
• InChiKey: GWJDWRQSNJIBAE-UHFFFAOYSA-N

物化性质

• 溶解度：
  可溶于氯仿、乙酸乙酯

计算性质

• 辛醇/水分配系数(LogP)：
  14.1
• 重原子数：
  120
• 可旋转键数：
  48
• 环数：
  13.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  269
• 氢给体数：
  0
• 氢受体数：
  24

文献信息

• CYCLITOLS AND THEIR DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS
  申请人：Normoxys, Inc.

  公开号：EP2111226A2

  公开（公告）日：2009-10-28
• Cyclitols and Their Derivatives and Their Therapeutic Applications
  申请人：Lehn Jean-Marie

  公开号：US20080200437A1

  公开（公告）日：2008-08-21

  The present invention is directed to polyphosphorylated and pyrophosphate derivatives of cyclitols. More particularly, the invention relates to polyphosphorylated and pyrophosphate derivatives of inositols. The invention also relates to compositions of the polyphosphorylated and pyrophosphate derivatives of inositol and other similar, more lipophilic derivatives, and their use as allosteric effectors, cell-signaling molecule analogs, and therapeutic agents.
• [EN] CYCLITOLS AND THEIR DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS<br/>[FR] CYCLITOLS, LEURS DÉRIVÉS, ET LEURS APPLICATIONS THÉRAPEUTIQUES
  申请人：OXYPLUS INC

  公开号：WO2008082658A2

  公开（公告）日：2008-07-10

  [EN] The present invention is directed to polyphosphorylated and pyrophosphate derivatives of cyclitols. More particularly, the invention relates to polyphosphorylated and pyrophosphate derivatives of inositols. The invention also relates to compositions of the polyphosphorylated and pyrophosphate derivatives of inositol and other similar, more lipophilic derivatives, and their use as allosteric effectors, cell-signaling molecule analogs, and therapeutic agents.
  [FR] L'invention porte sur des dérivées polyphosphorylés et des pyrophosphate de cyclitols, et plus particulièrement, sur des dérivées polyphosphorylés et des pyrophosphates d'inositols. L'invention porte également sur des compositions de dérivées polyphosphorylés et de pyrophosphates d'inositols et d'autres semblables plus lipophiles, et sur leurs utilisations comme effecteurs allostériques, analogues de molécules de signalisation de cellules, et agents thérapeutiques.